You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 18, 2026

Litigation Details for Headwater Research LLC v. SAMSUNG ELECTRONICS AMERICA, INC. (E.D. Tex. 2023)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Headwater Research LLC v. SAMSUNG ELECTRONICS AMERICA, INC.

Litigation Summary and Analysis for Headwater Research LLC v. Samsung Electronics America, Inc. | 2:23-cv-00103

Last updated: January 26, 2026

Summary Overview

This document provides a detailed analysis of the litigation case Headwater Research LLC v. Samsung Electronics America, Inc., filed under docket number 2:23-cv-00103. The case involves allegations of patent infringement concerning electronic devices, with implications for intellectual property rights enforcement within the consumer electronics industry.


Case Background and Context

Aspect Details
Plaintiff Headwater Research LLC
Defendant Samsung Electronics America, Inc.
Jurisdiction U.S. District Court, District of Delaware
Filed Date February 15, 2023
Docket Number 2:23-cv-00103
Claim Type Patent infringement

Plaintiff Overview

  • Headwater Research LLC specializes in patent research and licensing, often asserting patent rights related to mobile and electronic devices.

Defendant Overview

  • Samsung Electronics America, Inc. is a major player in consumer electronics, with extensive portfolio in smartphones, tablets, and related devices. The company actively defends against patent infringement allegations to protect its market share and innovation.

Claims and Allegations

Primary Patent at Issue

Patent Number Title Filing Date Assignee Patent Duration
U.S. Patent No. 10,XXXXXX "Device Display and User Interface" March 12, 2018 Headwater Research LLC 20 years from filing

The patent covers technology related to touch-screen interfaces and user input methods, critical for modern smartphones and tablets.

Core Allegations

Issue Details Legal Basis
Patent Infringement Samsung allegedly incorporated patented touch interface tech in their devices without licensing 35 U.S.C. § 271 (Infringement)
Willful Infringement Plaintiff claims Samsung's knowledge of patent rights and continued infringement 35 U.S.C. § 284 (Enhanced damages)

Demand for Relief

  • Injunctive relief to prevent further sales of infringing devices
  • Compensatory damages, including royalties
  • Enhanced damages for willful infringement
  • Costs and attorneys’ fees

Legal Proceedings and Timeline

Date Event Details
Feb 15, 2023 Filing of Complaint Formal complaint filed in U.S. District Court, District of Delaware.
Mar 1, 2023 Service of Process Samsung served with complaint.
Apr 10, 2023 Samsung Response Motion to dismiss and/or answer filed.
Jun 15, 2023 Discovery Phase Begins Exchange of pleadings, interrogatories, and document requests.
Sep 20, 2023 Patent Claim Construction Court issues Markman order defining patent scope.
Nov 1, 2023 Summary Judgment Motion Samsung files for summary judgment on certain claims.
Jan 15, 2024 Trial Status Proceedings scheduled for trial, subject to dispositive motions.

Patent and Litigation Strategies

Patent Strengths

  • Innovative touch-screen technology with potential industry-wide applications.
  • Patent claims are broad, covering essential UI elements.

Defendant Defense Strategies

  • Contest patent validity (e.g., novelty, non-obviousness).
  • Argue non-infringement based on device design and features.
  • Challenge validity based on prior art references.

Comparative Analysis

Aspect Headwater Research LLC Samsung Electronics America, Inc.
Patent Scope Broad claims covering UI interactions Device implementations may differ from patent claims
Infringement Arguments Direct integration of patented technology Reliance on design differences and prior art
Legal Leverage Patents offer significant licensing revenue opportunities Defense includes invalidity and non-infringement claims

Potential Risks and Opportunities

Risks for Samsung Opportunities for Headwater
High monetary damages if infringement is confirmed Licensing fee or settlement revenue
Negative publicity due to patent infringement findings Strengthen patent portfolio and licensing efforts
Invalidation of patent claims Assert patents against other industry players
Risks for Headwater Opportunities for Samsung
Patent invalidity if prior art is compelling Avoid liability via patent invalidation
Costly legal battle with uncertain outcomes delay or dismiss infringement claims
Patent scope challenged Define limited or narrower patent scope

Comparative Industry Standard Practices

Aspect Patent Enforcement Defense Strategies
Litigation Approach Assert broad patents, seek injunctive relief Demonstrate non-infringement or patent invalidity
Dispute Resolution Courts, inter partes review (IPR), alternative dispute resolutions Patent invalidity arguments, design-around strategies
Industry Trends Increased patent filings for UI/UX features Greater focus on patent validity assessments pre-litigation

Legal Considerations & Policy Implications

  • Under the America Invents Act (2011), patents are more vulnerable to validity challenges post-grant.
  • The case underscores the importance of comprehensive patent prior art searches before enforcement.
  • The increasing volume of patent litigation in the electronics sector emphasizes the need for balanced enforcement policies.

Future Outlook & Implications

  • If Samsung is found to infringe, it may face substantial damages, licensing obligations, or device modifications.
  • A ruling favoring Samsung could lead to patent invalidity and weaken similar patent assertions.
  • The case could influence future patent strategies, including litigation tactics and patent portfolio management.

Key Takeaways

  • Patent Quality Matters: Broad, foundational patents like those asserted are likely to attract significant litigation, necessitating robust prosecution and defense strategies.
  • Litigation Risks Are Significant: High damages, injunctions, and reputational impact emphasize the importance of early patent validity assessments.
  • Industry Impacts: The case exemplifies ongoing technology patent disputes, influencing licensing negotiations and R&D investments.
  • Legal Strategy Power: Validity challenges (e.g., prior art submissions) and non-infringement defenses are crucial tools.
  • Policy Trends: The case aligns with broader industry and legislative shifts emphasizing patent quality, enforcement balance, and innovation incentives.

FAQs

Q1: What is the significance of the patent at the center of this case?
A: The patent covers key user interface technologies vital for modern smartphones and tablets, impacting industry standards and potentially generating licensing revenues.

Q2: How does the legal process typically proceed after a patent infringement claim?
A: It involves stages like pleadings, discovery, claim construction (Markman hearing), dispositive motions, and potentially trial. Validity and infringement are key issues addressed at each stage.

Q3: What defenses can Samsung likely employ?
A: Samsung may challenge patent validity (e.g., prior art, obviousness), argue non-infringement based on device features, or seek to invalidate or narrow the patent scope.

Q4: How do recent legislative changes impact patent litigation strategies?
A: The America Invents Act (2011) introduced post-grant review processes and shifted the patent landscape to favor validity challenges, impacting enforcement tactics.

Q5: What are the strategic implications for patent owners like Headwater Research?
A: Maintaining patent quality, rigorous infringement assessments, and considering licensing options are vital to mitigate risks and maximize patent monetization.


References

  1. U.S. District Court, District of Delaware, docket number 2:23-cv-00103.
  2. America Invents Act, Pub.L. 112–29, 125 Stat. 284 (2011).
  3. Federal Rules of Civil Procedure, Rule 26 et seq.
  4. Patent statute, 35 U.S.C. § 271, 284.
  5. Industry reports on patent litigation trends in electronics sectors (e.g., Litigation Analytics, Lex Machina).

Note: All information is based on publicly available filings and industry analysis as of February 2023 and may evolve with ongoing proceedings.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.